
Could Gold Hit a Do...


| Price and Volume | |
|---|---|
| Recent Price | 31.07 |
| 52 Week High | 32.86 |
| 52 Week Low | 18.29 |
| Avg. Daily Vol. (Mil) | 0.40 |
| Beta (3 year) | 1.07 |
| Share Related Items | |
| Mkt Cap (Mil) | 861.41 |
| Shares Out (Mil) | 27.72 |
| Float (Mil) | 18.80 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.30 |
| Current Ratio | 2.90 |
| LT Debt/ Equity | 0.06 |
| Total Debt / Equity | 0.10 |
| Valuation Ratios | |
| Price Earnings | 20.00 |
| Price/Sales | 1.28 |
| Price/Book | 3.65 |
| Price/Cash Flow | 14.20 |
| Per Share Data | |
| Earnings | 1.55 |
| Sales | 24.27 |
| Book Value | 8.52 |
| Cash Flow | 2.19 |
| Business Summary | |
|---|---|
| Bio-Reference Labs is engaged in offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. | |
| General Information | |
| 481 Edward H. Ross Drive
Elmwood Park, NJ 07407 |
|
| bioreference.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 2726 | |
| CEO: Dr. Marc D. Grodman,M.D. | |
| Short Interest | |
| Current Month (Mil) | 10.11 |
| Previous Month (Mil) | 10.29 |
| Short Interest Ratio (Days) | 23.60 |
| Management Effectiveness | |
| Return on Equity | 18.40 |
| Return on Assets | 13.10 |
| Return on Investments | 17.40 |
| Profitability | |
| Gross Margin | 50.10 |
| EBIT Margin | 11.60 |
| Profit Margin | 6.50 |